
Metagenomi
Discovering the next generation of gene-editing systems for use in treating genetic diseases.
Market cap
$55.7m
Enterprise value
($126m)
Share price
$1.48 MGX
Authorizing premium user...
Discovering the next generation of gene-editing systems for use in treating genetic diseases.